8 Organisations

Specialized Trial Services

Specialist providers such as central labs, imaging services, endpoint adjudication, and safety operations support.

Organisations
8
Countries
3
Source-verified
0

Clinical Trial Infrastructure

Specialized Trial Services matrix

Compare providers on the signals that matter for this role. Cells separate directly sourced evidence from source-informed inferences and open research questions.

8

providers compared

37

sourced or inferred cells

Evidence mix

Sourced37Likely0Not found2Needs review17
CompanyService typeSpecialized service category and delivery model.Psychedelic experienceEvidence specific to psychedelic trials or infrastructure.Clinical deliverySite, clinic, training, or delivery relevance.Protocol/therapy supportProtocol, therapy, training, endpoint, or assessment support.Regulatory / ethicsRegulatory, ethics, safety, or sensitive-trial support.Geography / catchmentSource-stated coverage and estimated regional relevance.Evidence depthReview freshness, source depth, and public evidence strength.
CenExelSite Networks & SMOs
Sourced

site-network-smo

Strong site-network fit. Center-level mapping should be handled separately because the research supports the U.S. network but not every center's psychedelic activity.

Sources [1][2][3][4] - 2026-06-18

Sourced

Dedicated capability

Dedicated psychedelics capability page supports specialized trial-services relevance.

Sources [1] - 2026-06-18

Needs review

Needs review

No reviewed matrix value yet.

Needs review

Needs review

No reviewed matrix value yet.

Needs review

Needs review

No reviewed matrix value yet.

Sourced

1 country + 1 known location

Use metro catchments only after center-level mapping. Participant-facing site network.

Sources [1][2][3][4] - 2026-06-18

Sourced

Verified Psychedelic Trial Experience

Dedicated psychedelics capability page; facilitator training, private dosing rooms, EEG/imaging consultation, and diverse enrollment strategy.

Sources [1][2][3][4] - 2026-06-18

Clerkenwell HealthSpecialized Trial Services
Sourced

CNS/psychedelic trial services

Built around sponsor-facing CNS and psychedelic research support.

Sources [1] - 2026-06-18

Sourced

Purpose-built psychedelic sites

Sources describe dedicated psychedelic clinical research infrastructure.

Sources [1] - 2026-06-18

Sourced

London + Doncaster

Current verified locations support participant-facing delivery.

Sources [1] - 2026-06-18

Sourced

Therapist trial expertise

Therapist-related trial expertise and psychiatric support are source-backed.

Sources [1] - 2026-06-18

Needs review

Needs review

No reviewed matrix value yet.

Sourced

United Kingdom

Use UK site catchments only around verified locations.

Sources [1] - 2026-06-18

Sourced

Verified

Multiple public sources support the record.

Sources [1] - 2026-06-18

ClinilabsCROs & Full-Service Trial Delivery
Sourced

full-service-cro

Strong CRO fit. Public sources support psychedelic trial participation and global CNS infrastructure, but dosing-site coverage should only be mapped where site conduct is confirmed.

Sources [1][2][3][4][5][6] - 2026-06-18

Sourced

Psychedelic study recruitment

Public psychedelic-study recruitment and sponsor partnership evidence support inclusion.

Sources [1] - 2026-06-18

Needs review

Needs review

No reviewed matrix value yet.

Needs review

Needs review

No reviewed matrix value yet.

Needs review

Needs review

No reviewed matrix value yet.

Sourced

5 countries + 2 known locations

Only around verified recruiting/dosing sites. Public recruitment into psychedelic studies.

Sources [1][2][3][4][5][6] - 2026-06-18

Sourced

Verified Psychedelic Trial Experience

CNS CRO with public CYB003 partnership and psychedelic-study recruitment.

Sources [1][2][3][4][5][6] - 2026-06-18

FluenceSpecialized Trial Services
Sourced

Clinical trial training

Fluence provides psychedelic clinical trial training and consulting services.

Sources [1] - 2026-06-18

Sourced

Named developers

Research cites named psychedelic drug developers as training/protocol clients.

Sources [1] - 2026-06-18

Not found

No patient site

Fluence is not a participant-facing clinical site.

Sources [1] - 2026-06-18

Sourced

Manuals + adherence

Protocol/manual support and adherence frameworks are source-backed.

Sources [1] - 2026-06-18

Sourced

Therapy fidelity

Training and adherence support are relevant to sensitive psychedelic trial delivery.

Sources [1] - 2026-06-18

Sourced

Multinational training

Training reach should not be converted into country coverage without office verification.

Sources [1] - 2026-06-18

Sourced

Verified source

Public Fluence services page supports this entry.

Sources [1] - 2026-06-18

MAC Clinical ResearchSite Networks & SMOs
Sourced

hybrid

Strong site-network and specialized-services fit. Use regional catchments around verified research sites only.

Sources [1][2][3][4][5] - 2026-06-18

Sourced

Verified Psychedelic Trial Experience

Purpose-built psychedelic testing suites, early-phase unit, controlled-substance manufacturing/distribution, and patient recruitment for relevant psychiatric/addiction populations.

Sources [1][2][3][4][5] - 2026-06-18

Needs review

Needs review

No reviewed matrix value yet.

Needs review

Needs review

No reviewed matrix value yet.

Sourced

Controlled-drug handling

Controlled-substance manufacturing/distribution and handling are source-backed.

Sources [1] - 2026-06-18

Sourced

1 country + 2 known locations

Regional catchments around verified sites only. Physical research and dosing facilities.

Sources [1][2][3][4][5] - 2026-06-18

Sourced

Verified Psychedelic Trial Experience

Purpose-built psychedelic testing suites, early-phase unit, controlled-substance manufacturing/distribution, and patient recruitment for relevant psychiatric/addiction populations.

Sources [1][2][3][4][5] - 2026-06-18

Numinus / Cedar Clinical ResearchSite Networks & SMOs
Sourced

hybrid

Model as one integrated stakeholder for now. If Blossom later splits subsidiaries/business units, Cedar Clinical Research and Numinus Training can become separate records.

Sources [1][2] - 2026-06-18

Sourced

Verified Psychedelic Trial Experience

Participant-facing psychedelic trial sites and therapist-training infrastructure with public MAPS and MindMed-related evidence.

Sources [1][2] - 2026-06-18

Needs review

Needs review

No reviewed matrix value yet.

Sourced

Therapist training

Numinus-linked training infrastructure supports specialized-services inclusion.

Sources [1][2] - 2026-06-18

Needs review

Needs review

No reviewed matrix value yet.

Sourced

2 countries + 2 known locations

Only around verified research clinics. Physical research sites and participant dosing.

Sources [1][2] - 2026-06-18

Sourced

Verified Psychedelic Trial Experience

Participant-facing psychedelic trial sites and therapist-training infrastructure with public MAPS and MindMed-related evidence.

Sources [1][2] - 2026-06-18

PsyCORESpecialized Trial Services
Sourced

Consortium/site enablement

PsyCORE self-describes SOP harmonization, site onboarding, and registry services.

Sources [1][2] - 2026-06-18

Needs review

Self-stated

The concept is psychedelic-specific but external corroboration is thin.

Sources [1][2] - 2026-06-18

Needs review

Needs review

Physical network and live operational sites are not verified.

Sources [1][2] - 2026-06-18

Sourced

SOP harmonization

SOP and site-onboarding claims are public but mostly self-described.

Sources [1][2] - 2026-06-18

Needs review

Needs review

No reviewed matrix value yet.

Not found

Not found

No verified operating geography or catchment was found.

Sources [1][2] - 2026-06-18

Needs review

Thin public evidence

Keep the record but flag for stronger corroboration.

Sources [1][2] - 2026-06-18

St Pancras Clinical ResearchSite Networks & SMOs
Sourced

Specialist site/SMO

Specialist clinical research site services support specialized inclusion.

Sources [1][2] - 2026-06-18

Sourced

Verified Psychedelic Trial Experience

UK site/SMO with dedicated psychedelic dosing room, controlled-drug capability, and neuropsychiatric/depression/AUD recruitment.

Sources [1][2] - 2026-06-18

Needs review

Needs review

No reviewed matrix value yet.

Needs review

Needs review

No reviewed matrix value yet.

Sourced

Controlled-drug capability

Controlled-drug capability is relevant to psychedelic trial operations.

Sources [1][2] - 2026-06-18

Sourced

1 country + 3 known locations

Regional catchments around verified clinics. Participant-facing physical research sites.

Sources [1][2] - 2026-06-18

Sourced

Verified Psychedelic Trial Experience

UK site/SMO with dedicated psychedelic dosing room, controlled-drug capability, and neuropsychiatric/depression/AUD recruitment.

Sources [1][2] - 2026-06-18

By country

All Organisations

United States

CenExel

U.S. site network with a dedicated psychedelics capability page, private dosing rooms, facilitator training, specialty assessment support, and participant enrollment infrastructure.

View Profile
United Kingdom

Clerkenwell Health

Other

UK psychedelic and CNS trial infrastructure provider with specialist trial sites, sponsor-facing psychiatric research support, recruitment pathways, and therapist-related trial expertise.

1 trial
View Profile
United States

Clinilabs

CNS-focused CRO with public psychedelic-study recruitment and sponsor partnership evidence, including Cybin's CYB003 program and Schedule I-enabled clinical infrastructure.

View Profile
United States

Fluence

Other

Specialized psychedelic clinical trial services provider focused on therapist and facilitator training, protocol/manual support, adherence frameworks, and sponsor-facing trial preparation.

View Profile
United Kingdom

MAC Clinical Research

Other

UK research-site network with psychedelic testing suites, early-phase infrastructure, controlled-drug capability, and participant recruitment for depression, PTSD, addiction, and related conditions.

1 trial
View Profile
Canada

Numinus / Cedar Clinical Research

Canadian psychedelic research-site and training infrastructure associated with Numinus and Cedar Clinical Research, with public evidence from MAPS-sponsored MDMA work and broader sponsor support.

View Profile

PsyCORE

Psychedelic clinical research consortium concept focused on SOP harmonization, site onboarding, patient registry workflows, and study-operations support, with limited external corroboration.

View Profile
United Kingdom

St Pancras Clinical Research

UK site-network and SMO-style research provider with a dedicated psychedelic dosing room, controlled-drug capability, and recruitment pathways for depression, AUD, and neuropsychiatric trials.

View Profile

Category guide

What specialized trial services do

Specialised trial-service organisations provide focused capabilities that do not fit cleanly into a generic CRO, site, recruitment, or software role. In psychedelic research, this may mean therapist training, protocol support, specialist clinics, assessment operations, session support, safety procedures, or delivery infrastructure specific to psychedelic studies.

This category is useful because psychedelic trials depend on human and operational routines that are easy to under-specify. Protocol design, therapist training, participant preparation, dosing-session logistics, integration support, assessment quality, and safety workflows can all affect whether a study is feasible and credible.

Questions to ask

  • What exact specialist service does the organisation provide, and where does it sit in the trial workflow?
  • Is the psychedelic-specific experience direct, source-backed, and current?
  • Does the service require a physical catchment area, a clinic footprint, trained personnel, or a remote delivery model?

Signals we track

  • service type
  • psychedelic-specific experience
  • clinical delivery relevance
  • protocol or therapy support
  • geography and catchment

The matrix above keeps source-backed cells separate from fields that still need review, and keeps broad service claims distinct from verified locations or named coverage.